Home › Lung Diseases › Colorado
Lung Diseases clinical trials in Colorado
12 studies for Lung Diseases are looking for participants at sites in Colorado.
Cities in Colorado
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus, Aurora
- University of Colorado Anschutz Medical Campus, Aurora
- University of Colorado Clinical and Translational Research Center, Aurora
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- National Jewish Health Medical Center, Denver
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Paradigm Clinical Research, LLC, Wheat Ridge
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140American Lung Association (ALA) Lung Health Cohort
- National Jewish Health, Denver
RecruitingObservational studyHealthy volunteers welcome
Ages 25 to 35 · All sexes · Updated Sep 23, 2026 · NCT04543461A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Colorado ENT & Allergy, Colorado Springs
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 22, 2026 · NCT06977581Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Colorado Cancer Center, Aurora
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- USO - Rocky Mountain Cancer Centers, Lone Tree
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- National Jewish Health, Denver
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Colorado Springs
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05624450Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Rocky Mountain Cancer Centers, Boulder
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06765109Deep Functional Phenotyping of the ALA Lung Health Cohort
- National Jewish Health, Denver
RecruitingObservational studyHealthy volunteers welcome
Ages 25 to 35 · All sexes · Updated Jul 17, 2026 · NCT06177717Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
- University of Colorado - Anschutz Medical Campus, Aurora
RecruitingObservational study
Ages 45 to 90 · All sexes · Updated May 1, 2026 · NCT03297775From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.